Table 3.
OH (n = 72) | HP (n = 15) | OHP (n = 187) | OP (n = 63) | P value | |
---|---|---|---|---|---|
BMI groupsa | |||||
Lean | 48 (66.7%) | 8 (53.3%) | 117 (62.6%) | 44 (69.8%) | 0.56 |
Overweight | 16 (22.2%) | 4 (26.7%) | 44 (23.5%) | 8 (12.7%) | |
Obese | 8 (11.1%) | 3 (20.0%) | 26 (13.9%) | 11 (17.5%) | |
HOMA‐IR (95%CI)b | 1.86 (1.50‐2.33) | 1.66 (1.05‐2.67) | 1.74 (1.54‐1.98) | 1.78 (1.42‐2.24) | 0.95 |
M value (95%CI)b | 8.10 (7.40‐8.86) | 7.62 (6.24‐9.07) | 7.70 (7.28‐8.15) | 8.69 (7.89‐9.57) | 0.18 |
O, oligo/anovulation; H, hyperandrogenism; P, polycystic ovary morphology; BMI, body mass index; HOMA‐IR, homeostatic model assessment for insulin resistance.
Fisher's exact test.
Welsh's ANOVA.